Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology. (July 2021)
- Record Type:
- Journal Article
- Title:
- Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology. (July 2021)
- Main Title:
- Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology
- Authors:
- Sebastiani, Gian Domenico
Spinelli, Francesca Romana
Bartoloni, Elena
Bortoluzzi, Alessandra
Bozzolo, Enrica
Canofari, Claudia
Canti, Valentina
Conigliaro, Paola
Ditto, Maria Chiara
Emmi, Giacomo
Franceschini, Franco
Frassi, Micol
Iaccarino, Luca
Iuliano, Annamaria
Manfredi, Angelo
Pacucci, Viviana
Parisi, Simone
Pazzola, Giulia
Perricone, Roberto
Prevete, Immacolata
Ramirez, Giuseppe Alvise
Scarpato, Salvatore
Scirocco, Chiara
Silvagni, Ettore
Zen, Margherita
Zanetti, Anna
Carrara, Greta
Scirè, Carlo Alberto
Conti, Fabrizio
Doria, Andrea - Abstract:
- Objective: To report baseline data of SLE patients enrolled in the Lupus Italian Registry (LIRE). Methods: Patients affected by SLE aged ≥ 16 years were consecutively recruited in a multicenter prospective study comparing two cohorts: patients starting biologic immunosuppressants (BC) and patients starting non-biologic immunosuppresants (NBC). Results: 308 patients were enrolled, 179 in NBC and 129 in BC. Mean age at disease onset and at diagnosis was significantly higher in NBC (p = 0.023, p = 0.045, respectively). Disease duration was longer in BC (p = 0.022). Patients in BC presented arthritis more frequently (p = 0.024), those in NBC nephropathy (p = 0.03). Quality of life was worse in BC (p = 0.031). Anti-dsDNA, low C3, were significantly more frequent in BC (p < 0.001, p = 0.009, respectively). Mycophenolate, methotrexate and azathioprine were the drugs more frequently prescribed in NBC, Belimumab and Rituximab in BC. Conclusion: The predominant organ involvement was different in the two cohorts: kidney involvement predominated in NBC, joint involvement in BC. Despite the younger age at disease onset, patients of the BC had a longer disease duration and more frequently had taken a cumulative prednisone dosage greater than 10 g. Even the pattern of clinical manifestations inducing to prescribe biological rather than conventional immunosuppressants was quite different. Keywords: Autoantibody(ies), autoimmune disease, belimumab, cohort studies, glucocorticoids,Objective: To report baseline data of SLE patients enrolled in the Lupus Italian Registry (LIRE). Methods: Patients affected by SLE aged ≥ 16 years were consecutively recruited in a multicenter prospective study comparing two cohorts: patients starting biologic immunosuppressants (BC) and patients starting non-biologic immunosuppresants (NBC). Results: 308 patients were enrolled, 179 in NBC and 129 in BC. Mean age at disease onset and at diagnosis was significantly higher in NBC (p = 0.023, p = 0.045, respectively). Disease duration was longer in BC (p = 0.022). Patients in BC presented arthritis more frequently (p = 0.024), those in NBC nephropathy (p = 0.03). Quality of life was worse in BC (p = 0.031). Anti-dsDNA, low C3, were significantly more frequent in BC (p < 0.001, p = 0.009, respectively). Mycophenolate, methotrexate and azathioprine were the drugs more frequently prescribed in NBC, Belimumab and Rituximab in BC. Conclusion: The predominant organ involvement was different in the two cohorts: kidney involvement predominated in NBC, joint involvement in BC. Despite the younger age at disease onset, patients of the BC had a longer disease duration and more frequently had taken a cumulative prednisone dosage greater than 10 g. Even the pattern of clinical manifestations inducing to prescribe biological rather than conventional immunosuppressants was quite different. Keywords: Autoantibody(ies), autoimmune disease, belimumab, cohort studies, glucocorticoids, immunosuppressants, rituximab, systemic lupus erythematosus … (more)
- Is Part Of:
- Lupus. Volume 30:Number 8(2021)
- Journal:
- Lupus
- Issue:
- Volume 30:Number 8(2021)
- Issue Display:
- Volume 30, Issue 8 (2021)
- Year:
- 2021
- Volume:
- 30
- Issue:
- 8
- Issue Sort Value:
- 2021-0030-0008-0000
- Page Start:
- 1233
- Page End:
- 1243
- Publication Date:
- 2021-07
- Subjects:
- Systemic lupus erythematosus -- Periodicals
616.772005 - Journal URLs:
- http://journals.sagepub.com/home/lup ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/09612033211012470 ↗
- Languages:
- English
- ISSNs:
- 0961-2033
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15773.xml